Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune & Transcriptomic Responses to TIV & ATIV in Healthy Children
NCT01682369Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Sep 2012
- Primary completion
- Feb 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Fluzone Trivalent in influenza (6 arms), sponsored by University of Oxford. Primary endpoint: Descriptive analyses of gene expression profiles at 56 days. Started Sep 2012; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01682369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01682369.